Valuation : Amgen Inc.

Market Cap 20TCr 6,73400Cr 18TCr 17TCr 15TCr 28TCr 19,49000Cr 28TCr 1,97700Cr 76TCr 9,91600Cr 77TCr 75TCr 31,33200Cr P/E 2026 *
23.9x
P/E 2027 * 21.3x
Enterprise Value 25TCr 8,10300Cr 21TCr 20TCr 18TCr 34TCr 23,45300Cr 34TCr 2,37900Cr 91TCr 11,93200Cr 92TCr 90TCr 37,70400Cr EV / Sales 2026 *
6.3x
EV / Sales 2027 * 5.96x
Free-Float
99.77%
Yield 2026 *
2.67%
Yield 2027 * 2.82%
1 day-1.84%
1 week-12.57%
Current month-10.61%
1 month-6.98%
3 months+11.11%
6 months+6.67%
1 week 3.18
Extreme 3.18
3.68
1 month 3.18
Extreme 3.18
3.68
Current year 2.6
Extreme 2.6
3.68
1 year 2.6
Extreme 2.6
3.68
3 years 2.6
Extreme 2.6
3.68
5 years 2.6
Extreme 2.6
3.68
10 years 2.6
Extreme 2.6
3.68
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Chief Tech/Sci/R&D Officer 57 01/06/2023
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%-12.57% - - 20TCr
-0.65%-2.93%+47.70%+86.17% 99TCr
-0.29%-3.51%+49.15%+62.35% 64TCr
+0.83%+0.26%+17.76%+72.25% 45TCr
-0.38%-3.59%+30.13%+35.17% 34TCr
-0.09%-13.54%+13.34%+24.95% 26TCr
-0.43%-2.48%-0.73%+9.58% 25TCr
-1.34%-13.70%+36.53%+44.96% 20TCr
-3.44%-7.51%-20.63%-59.44% 19TCr
-0.75%-4.82%+25.46%+87.14% 18TCr
Average -0.84%-5.76%+22.08%+40.35% 38.94TCr
Weighted average by Cap. -0.58%-4.42%+30.96%+54.95%

Financials

2026 *2027 *
Net sales 3.89TCr 1,28500Cr 3.35TCr 3.18TCr 2.88TCr 5.4TCr 3,72000Cr 5.43TCr 38TCr 15TCr 1,89300Cr 15TCr 14TCr 5,98000Cr 4.02TCr 1,32800Cr 3.47TCr 3.28TCr 2.98TCr 5.58TCr 3,84400Cr 5.61TCr 39TCr 15TCr 1,95500Cr 15TCr 15TCr 6,17900Cr
Net income 869.13Cr 29TCr 748.84Cr 709.05Cr 642.69Cr 1.21TCr 83TCr 1.21TCr 8.42TCr 3.24TCr 42TCr 3.26TCr 3.19TCr 1,33500Cr 936.25Cr 31TCr 806.68Cr 763.81Cr 692.32Cr 1.3TCr 89TCr 1.31TCr 9.07TCr 3.49TCr 46TCr 3.52TCr 3.44TCr 1,43800Cr
Net Debt 4.15TCr 1,36900Cr 3.57TCr 3.38TCr 3.07TCr 5.76TCr 3,96300Cr 5.78TCr 40TCr 15TCr 2,01600Cr 16TCr 15TCr 6,37100Cr 3.58TCr 1,18200Cr 3.09TCr 2.92TCr 2.65TCr 4.97TCr 3,42200Cr 4.99TCr 35TCr 13TCr 1,74100Cr 13TCr 13TCr 5,50100Cr
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
11/26/11 THB 3.200 -1.84% 64,669
10/26/10 THB 3.260 +1.24% 61,587
09/26/09 THB 3.220 -5.85% 2,68,486
08/26/08 THB 3.420 -6.56% 5,873
07/26/07 THB 3.660 0.00% 54,606
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
377.35USD
Average target price
388.03USD
Spread / Average Target
+2.83%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!